Trial Studies Gold Nanoparticles as Way to Eliminate Localized Prostate Cancer

Trial Studies Gold Nanoparticles as Way to Eliminate Localized Prostate Cancer
A new approach that uses light-activated gold nanoparticles is being tested in a small clinical trial as a way to eliminate prostate cancer in patients with localized tumors. The method is thought to be precise enough to avoid negative effects such as incontinence and impotence, and could be an alternative to radical treatments or active monitoring. “This therapy could be life-changing for men diagnosed with prostate cancer,” Steven Canfield, MD, chair of the division of urology at Texas' McGovern Medical School at UTHealth, said in a press release. Canfield recognized the potential of the nanoparticles to treat prostate cancer and helped develop the trial. Treatments for localized prostate cancer — which include prostate surgery, radiation therapy, and hormone therapy — are typically associated with adverse events that can affect patients' quality of life. Active monitoring is now being offered as an alternative to radical treatments, but despite having fewer adverse events and similar survival rates at 10 years, patients still face a higher risk of having their cancer spread to distant regions. Nanospectra Biosciences' gold nanoparticles are being developed as a way to eliminate prostate cancer without the harmful side effects of other approaches. “The side effects of current prostate cancer treatments can be extremely traumatic. This new technology holds the potential to eliminate those life-altering effects, while still removing the cancer tissue and reducing hospital and recovery time,” Canfield said. The approach is called 
Subscribe or to access all post and page content.